Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
PEPG
PEPG
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PEPG News
PepGen Appoints New Chief Business Officer with 160,000 Stock Options Grant
Dec 09 2025
Newsfilter
Meihua International Medical Technologies, Fly-E Group, and Other Major Stocks Decline in Pre-Market Trading on Monday
Dec 08 2025
Benzinga
PepGen Appoints Joseph Vittiglio as Chief Business and Legal Officer
Dec 08 2025
Newsfilter
Sarepta's Shares Climb Following Encouraging News on DM1 Treatment
Nov 25 2025
NASDAQ.COM
PepGen (PEPG) Price Target Raised by 17.65% to $10.20
Nov 17 2025
NASDAQ.COM
Dyne and PepGen Surge as Likely Winners from Novartis/Avidity Agreement
Oct 27 2025
SeekingAlpha
PepGen Unveils Oral Presentations at the 30th Annual World Muscle Society International Congress
Oct 02 2025
Newsfilter
Biotech Stocks Recover in After-Hours Trading Driven by Positive Sector Trends
Oct 01 2025
NASDAQ.COM
Wedbush Keeps Outperform Rating for PepGen, Reduces Price Target to $8
Sep 30 2025
Benzinga
PepGen Secures $115 Million Through Public Offering
Sep 26 2025
Yahoo Finance
PepGen Completes Underwritten Public Offering of Common Stock and Full Exercise of Underwriters' Option for Additional Shares
Sep 26 2025
Newsfilter
Stifel Keeps Buy Rating on PepGen and Increases Price Target to $12
Sep 25 2025
Benzinga
S&P 500 Declines 1%; Accenture Reports Positive Earnings
Sep 25 2025
Benzinga
Nasdaq Declines More Than 1%; US Initial Jobless Claims Decrease
Sep 25 2025
Benzinga
PepGen Achieves Record Splicing Correction in Dystrophy Patients, Stock Price Soars 100%
Sep 25 2025
Benzinga
What’s Behind the 125% Surge in PepGen Stock (PEPG) Today?
Sep 25 2025
TipRanks
Show More News
